Cullinan Therapeutics, Inc. CGEM Other Income (Expense)
Other Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Cullinan Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s other income (expense)?
- Cullinan Therapeutics, Inc. (CGEM) reported other income (expense) of -$62K in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s other income (expense) changed year-over-year?
- Cullinan Therapeutics, Inc.'s other income (expense) increased by 27.1% year-over-year, from -$85K to -$62K.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s other income (expense)?
- Over 2 years (2022 to 2025), Cullinan Therapeutics, Inc.'s other income (expense) has grown at a 178.8% compound annual growth rate (CAGR), from $57K to -$443K.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.